Flexion Therapeutics, Inc.
(NASDAQ : FLXN)

( )
FLXN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.62%190.361.2%$564.46m
GILDGilead Sciences, Inc.
-0.52%70.550.9%$491.72m
BIIBBiogen Inc.
-1.73%313.551.3%$448.17m
CELGCelgene Corporation
-0.87%69.631.2%$426.13m
ILMNIllumina, Inc.
-0.95%308.233.5%$394.71m
REGNRegeneron Pharmaceuticals, Inc.
-1.41%337.292.6%$283.70m
VRTXVertex Pharmaceuticals Incorporated
-3.36%164.581.9%$265.75m
ALXNAlexion Pharmaceuticals, Inc.
-2.03%116.112.0%$195.76m
AAgilent Technologies, Inc.
-1.32%63.491.5%$175.37m
EXASExact Sciences Corporation
-1.38%68.4525.3%$145.96m
LGNDLigand Pharmaceuticals Incorporated
-0.42%147.8023.3%$142.63m
SRPTSarepta Therapeutics, Inc.
-4.09%111.9916.4%$134.89m
ECYTEndocyte, Inc.
-0.21%23.532.0%$121.26m
INCYIncyte Corporation
0.66%64.152.5%$116.78m
NKTRNektar Therapeutics
0.80%37.655.6%$109.74m

Company Profile

Flexion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The firm specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.